eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | sickle cell anemia |
| Comorbidity | C0282193|iron overload |
| Sentences | 18 |
| PubMedID- 25117103 | We assessed the frequency of the g71d mutation of the hamp gene and the h63d mutation of the hfe gene and the correlation between these mutations as well as the correlation between them and the iron overload in sickle cell disease (scd) patients. |
| PubMedID- 23946212 | We report a prospective, randomized, phase ii study of deferasirox and deferoxamine (dfo) in sickle cell disease patients with transfusional iron overload, with all patients continuing on deferasirox after 24 weeks, for up to 2 years. |
| PubMedID- 22332939 | Serum ferritin and total units transfused for assessing iron overload in adults with sickle cell disease. |
| PubMedID- 21681718 | [iron overload in sickle cell anemia : a study of 94 patients]. |
| PubMedID- 24319218 | Consequences and management of iron overload in sickle cell disease. |
| PubMedID- 22120913 | Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention. |
| PubMedID- 24664847 | Cardiac iron overload in sickle-cell disease. |
| PubMedID- 21452907 | Pharmacoeconomic considerations in treating iron overload in patients with beta-thalassaemia, sickle cell disease and myelodysplastic syndromes in the us: a literature review. |
| PubMedID- 24893174 | Deferasirox for managing transfusional iron overload in people with sickle cell disease. |
| PubMedID- 22760067 | Two-year analysis of efficacy and safety of deferasirox treatment for transfusional iron overload in sickle cell anemia patients. |
| PubMedID- 25711464 | Objective: to assess the prevalence of iron overload in adults with sickle cell disease (scd) not on a chronic transfusion protocol. |
| PubMedID- 23580874 | This case-control study of only 30 patients demonstrates a clear difference between sickle cell anemia patients with and without iron overload by evidence of a distinct pathophysiology response of the immune system and the oxidative stress to iron overload. |
| PubMedID- 21786315 | Chronic simple hypertransfusion (every 3 to 4 weeks) effectively prevents secondary stroke in children with sickle cell anemia but leads to iron overload despite chelation therapy. |
| PubMedID- 20490352 | iron overload in sickle cell disease. |
| PubMedID- 20862206 | [8] provides an overview of transfusional iron overload patients with sickle cell disease, highlighting how to prevent iron overload in this disorder. |
| PubMedID- 20687088 | Deferasirox for managing transfusional iron overload in people with sickle cell disease. |
| PubMedID- 23018567 | Treatment of iron overload among women with sickle cell anemia of childbearing potential is important to avoid possible cdp in newborns. |
| PubMedID- 22753840 | Hepatopulmonary syndrome associated with iron overload in sickle cell anaemia. |
Page: 1